How are Postural Orthostatic Tachycardia Syndrome (POTS) symptoms managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Postural Orthostatic Tachycardia Syndrome (POTS) Symptoms

The most effective management of POTS symptoms requires a combination of non-pharmacological interventions including increased fluid and salt intake, physical reconditioning, and compression garments, with targeted medications added based on predominant symptoms. 1

Non-Pharmacological Interventions (First-Line)

Fluid and Salt Management

  • Increase fluid intake to 3 liters of water or electrolyte-balanced fluids daily 1
  • Liberalize sodium intake (5-10g or 1-2 teaspoons of table salt per day) 1
  • Avoid factors contributing to dehydration:
    • Alcohol consumption
    • Caffeine intake
    • Large heavy meals
    • Excessive heat exposure

Physical Reconditioning

  • Begin with horizontal exercise (rowing, swimming, recumbent biking) 2
  • Gradually progress to upright exercise as tolerated 2
  • Implement a formalized exercise program (supervised when possible) 1
  • Elevate the head of the bed with 4-6 inch (10-15 cm) blocks during sleep 1

Compression Garments

  • Use waist-high compression stockings to ensure sufficient central blood volume support 1
  • Consider abdominal binders for additional venous return support 2

Pharmacological Interventions (Based on Symptom Predominance)

For Palpitations/Tachycardia

  • Low-dose beta-blockers (gradually titrated): 1
    • Propranolol (especially for those with anxiety or migraine)
    • Bisoprolol
    • Metoprolol
    • Nebivolol
  • Calcium-channel blockers: 1
    • Diltiazem
    • Verapamil
  • Ivabradine: Consider for patients with severe fatigue exacerbated by beta-blockers 1

For Orthostatic Intolerance

  • Fludrocortisone: Up to 0.2 mg taken at night (monitor for hypokalemia) 1
  • Midodrine (2.5-10 mg): 1
    • First dose taken before getting out of bed
    • Last dose no later than 4 pm to avoid supine hypertension

Phenotype-Specific Approaches

Hyperadrenergic POTS

  • Beta-blockers (particularly non-selective ones like propranolol) 1, 3
  • Monitor for excessive sympathetic symptoms (tremor, anxiety)

Neuropathic POTS

  • Midodrine to enhance vascular tone 3
  • Pyridostigmine may be beneficial 1

Hypovolemic POTS

  • Focus on aggressive volume expansion 3
  • Salt tablets (avoid if causing nausea) 1

Managing Associated Symptoms

Dermatological Manifestations

  • Common in POTS patients (77% report rash, >50% report Raynaud's phenomenon) 4
  • Most commonly found on arms, legs, and trunk 4
  • May require specific dermatological treatment if symptomatic

Cognitive Symptoms ("Brain Fog")

  • Ensure adequate hydration and salt intake 5
  • Consider cognitive rehabilitation techniques

Important Considerations and Pitfalls

  • No FDA-approved medications specifically for POTS exist 5
  • Avoid medications that worsen orthostatic symptoms (diuretics, vasodilators) 1
  • Salt loading is contraindicated in patients with cardiac dysfunction, heart failure, uncontrolled hypertension, or chronic kidney disease 1
  • Monitor for supine hypertension when using vasoconstrictors 1
  • Symptoms may be exacerbated by deconditioning, creating a vicious cycle 6

By systematically addressing both the hemodynamic abnormalities and specific symptoms of POTS, most patients can experience significant improvement in quality of life and functional capacity.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Exercise and non-pharmacological treatment of POTS.

Autonomic neuroscience : basic & clinical, 2018

Research

Dermatological Manifestations of Postural Tachycardia Syndrome Are Common and Diverse.

Journal of clinical neurology (Seoul, Korea), 2016

Research

Pharmacotherapy for postural tachycardia syndrome.

Autonomic neuroscience : basic & clinical, 2018

Research

Postural tachycardia syndrome (POTS).

Journal of cardiovascular electrophysiology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.